Attiva gli avvisi di lavoro via e-mail!
Celltrion Healthcare Italy recherche un Key Account Manager pour le sud de l'Italie. Le candidat idéal a une expérience reconnue dans le secteur pharmaceutique et une formation scientifique, ainsi qu'une forte capacité à établir et maintenir des relations avec divers acteurs pour assurer l'accès aux produits de l'entreprise.
Italy_Key Account Manager South Italy page is loaded
Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.
We are searching for highly motivated Pharma Key Account Manager (KAM) with a good scientific background and a previous experience in a similar role to join our Sales Department.
Celltrion Healthcare Italy is a rapidly developing company with a strong product pipeline across multiple therapeutic areas.
Candidates would have 8 years of previous experience as best, but attitude will be the first driver for our choice. The ideal ones are team builder, proactive, flexible and open-minded, with an energetic and result-oriented attitude, highly motivated to contribute to the growth and to grow with our Company in Italy.
Key responsibilities:
Essential requirements:
Workplace: South Italy
Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.